Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide function in atherosclerosis.

K E Matthys1, H Bult

  • 1University of Antwerp (UIA) Division of Pharmacology Wilrijk Antwerp B2610 Belgium.

Mediators of Inflammation
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells.

British journal of pharmacology·2009
Same author

Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells.

British journal of pharmacology·2008
Same author

Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis.

British journal of pharmacology·2007
Same author

Gene expression profiling of LPS-stimulated murine macrophages and role of the NF-kappaB and PI3K/mTOR signaling pathways.

Annals of the New York Academy of Sciences·2007
Same author

Altered Ca2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions.

Cell calcium·2006
Same author

Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease.

Cardiovascular & hematological disorders drug targets·2006
Same journal

Moxibustion Modulates ALOX15-Mediated Lipid Peroxidation to Inhibit Ferroptosis in Synovial Inflammatory Injury of Rheumatoid Arthritis.

Mediators of inflammation·2026
Same journal

Development and Validation of a Cytokine-Based Predictive Model for Acute GvHD and Composite Outcomes in ATG-Based Haploidentical Hematopoietic Stem Cell Transplantation.

Mediators of inflammation·2026
Same journal

Effects of Livergol and Hydroalcoholic Extracts of Barberry, Jujube, and Flixweed on Oxidative Stress and Inflammatory Gene Expression in a MASLD Animal Model.

Mediators of inflammation·2026
Same journal

Immune Gene INHBA is Associated With Osteoarthritic Cartilage Damage and May Mediate the Temporal Activation of the TGF-β/p38 MAPK Pathway: Integrating Multiomics Machine Learning and Experimental Validation.

Mediators of inflammation·2026
Same journal

RETRACTION: IκB Kinase Inhibitor VII Modulates Sepsis-Induced Excessive Inflammation and Cardiac Dysfunction in 5/6 Nephrectomized Mice.

Mediators of inflammation·2026
Same journal

A Novel CAF-Related Signature for Precise Prediction of Clinical Outcomes and Immunotherapy Response for Breast Cancer Patients: Based on Multiomics Analyses and Experimental Validation.

Mediators of inflammation·2026
See all related articles

Atherosclerosis impairs nitric oxide (NO) regulation, affecting vascular tone and potentially leading to heart issues. Research explores whether NO dysfunction causes or results from this inflammatory artery disease.

Area of Science:

  • Cardiovascular Science
  • Inflammation Biology
  • Endothelial Function

Background:

  • Atherosclerosis is a chronic inflammatory arterial disease.
  • Endothelial dysfunction, involving nitric oxide (NO) regulation, is an early event.
  • The role of NO produced by constitutive endothelial NO synthase (eNOS) and inducible NO synthase (iNOS) in atherogenesis is debated.

Purpose of the Study:

  • To explore the role of endothelial nitric oxide (NO) dysfunction in atherosclerosis.
  • To investigate whether NO production defects cause or are a consequence of atherosclerotic lesion development.
  • To understand the dual role of NO from eNOS and iNOS in vascular health and disease.

Main Methods:

  • Analysis of endothelial nitric oxide synthase (eNOS) and inducible NO synthase (iNOS) activity in the context of atherosclerosis.

Related Experiment Videos

  • Review of evidence regarding the impact of NO on vascular tone, smooth muscle cell proliferation, and leukocyte adhesion.
  • Examination of the interplay between NO, reactive oxygen intermediates, and vascular wall integrity.

    • Main Results:

    • Endothelial dysfunction disrupts vascular tone regulation via impaired nitric oxide (NO) production.
    • Constitutive NO release from eNOS appears protective against atherogenesis.
    • Inducible NO synthase (iNOS) may compensate for NO deficiency but can also cause vascular damage.

    Conclusions:

    • Endothelial NO dysfunction is a critical factor in atherosclerosis, impacting vascular tone and potentially predisposing to cardiac events.
    • While eNOS-derived NO is protective, iNOS-derived NO has a complex role, potentially beneficial but also harmful.
    • Further research is needed to clarify the causal relationship between NO dysfunction and atherosclerotic lesion formation.